Navigation Links
Improper use of biocides in food production may endanger public health
Date:1/6/2014

ervoir of microorganisms, and biofilm formation is a major virulence factor in human infections. Biofilm formation also boosts operation and maintenance costs in food production by interfering with heat exchangers, plugging filters and blocking tubes in water distribution systems.

The study's results are important in demonstrating the need to guide policies to prevent improper use of biocides, says Capita.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1 2

Related biology news :

1. A trial to find out the effectiveness of biocides against Vespa velutina
2. New synthetic biology technique boosts microbial production of diesel fuel
3. Sexual reproduction brings long-term benefits, study shows
4. How the ecological risks of extended bioenergy production can be reduced
5. WPI team scales-up production of biopolymer microthreads
6. Higher risk of birth defects from assisted reproduction
7. Discovery of plant proteins may boost agricultural yields and biofuel production
8. Cellular secrets of plant fatty acid production understood
9. European Society of Human Reproduction and Embryology 28th Annual Meeting -- Istanbul
10. Agricultural expert outlines path for developing nations to double food production, meet 2050 demand
11. Production of chemicals without petroleum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... -- As part of our commitment to offering the ... announce the release of a new reader that will ... data that they need. The Atlas 2000 ... readers. Many such devices have serious shortcomings when it ... models force users to navigate numerous complicated steps in ...
(Date:11/21/2014)... Nov. 20, 2014 C-Labs LLC, a leading ... of Things (IoT), today announced the appointment of ... officer. Previously a strategic advisor to the firm, Mr. ... Mr. Traynor is based out of the C-Labs office ... to Chris Muench , Chief Executive Officer. ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
... HIV vaccine based on a genetically modified killed whole ... and Drug Administration (FDA) to start human clinical trials. ... at The University of Western Ontario, with the support ... having already proven to stimulate strong immune responses in ...
... images of the interior of a single living cell, ... cargo without injuring or damaging the cell, has been ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab). This highly ... be applied to biosensing and single-cell electrophysiology. A ...
... Forest thinning to help prevent or reduce severe wildfire ... saved by successful fire prevention, a new study concludes. ... as restoration of forest structure or health, wildlife enhancement or ... of them, scientists say. In research just published in ...
Cached Biology News:HIV/AIDS vaccine developed at Western proceeding to human clinical trials 2A single cell endoscope 2A single cell endoscope 3Forest health versus global warming: Fuel reduction likely to increase carbon emissions 2
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)... Md. , Dec. 17, 2014 CASI ... company dedicated to the acquisition, development and commercialization of ... for the global market with a primary commercial focus ... it has been granted a Type C meeting with ... the meeting will be held in February 2015.  During ...
(Date:12/15/2014)... Israel , Dec. 15, 2014 /PRNewswire/ ... a leading developer of adult stem cell technologies for ... Therapeutics Ltd. was awarded a grant of approximately $1.1 ... the Chief Scientist (OCS).  This is the eighth year ... from the Office of the Chief Scientist, which is ...
(Date:12/15/2014)... COPENHAGEN, Denmark , Dec. 15, 2014 /PRNewswire/ ... its innovative TransCon technology to address significant unmet ... from its ongoing Phase 2 pediatric study to ... growth hormone deficiency, or GHD.  This interim analysis ... the anticipated total enrollment in the study, completing ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4
... ON Scientists at the University of Toronto, Stanford and ... and function of candidate prescription drugs on human cells, including ... larger scale than ever before. The researchers say their ... of a variety of diseases and biologic actions, and will ...
... -- Researchers in the Materials Science and Technology ... demonstrated electrical injection, detection and precession of spin ... device technology, at temperatures up to 225 degrees ... spin accumulation in Si is viable as a ...
... 2011 Advanced Life Sciences Holdings, Inc. ... development and commercialization of novel drugs in the therapeutic ... that it has suspended operations and terminated its staff ... (Logo:   http://photos.prnewswire.com/prnh/20080218/ALSLOGO ) "We ...
Cached Biology Technology:University of Toronto chemistry technology promises more effective prescription drug therapies 2NRL scientists achieve high temperature milestone in silicon spintronics 2NRL scientists achieve high temperature milestone in silicon spintronics 3Advanced Life Sciences Suspends Operations 2
Ms anti-Cyclophilin D...
Protein Kinase D2 Immunogen: Human protein kinase D2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Request Info...
Immunogen: Recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies from E. coli and purified by preparative SDS-PAGE. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: